The incidence of inflammatory bowel disease (IBD) is increasing in all patient groups but rates are rising fastest in non-Hispanic Black patients. Clinicians are failing to recognize IBD in these high- incidence populations, leading to delays in diagnosis and worse long-term outcomes. Inequities in preventative care, health care worker bias, and social determinants of health (SDoH) are all barriers to the prompt recognition of IBD and achieving the best possible outcomes in IBD care.
Specific steps must be taken to achieve equitable IBD care. All health care staff members should be included in diversity and inclusion training efforts and education to address unconscious bias. Practicing U.S. gastroenterologists are not representative of the population they care for and concerted efforts are needed to improve diversity, starting with undergraduate trainees interested in gastroenterology.
In this podcast installment of a multi-prong diversity, equity, and inclusion (DEI) series, Monica E. Peek, MD, MPH, MSc; Sophie Balzora, MD, FACG; and Nana Bernasko, CRNP, DNP, WHNP-BC, will discuss strategies vital to combating inequities in IBD. The conversation will describe modern-day issues in how unconscious bias, health disparities, and health inequities all influence quality of care, and will provide real-world strategies to improve IBD care for all patients.
At the end of this CME/CE activity, participants should be able to analyze the influence of unconscious bias, health disparities, and health inequities on the care of patients with inflammatory bowel disease.
Supported by an educational grant from Johnson & Johnson.
Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, pharmacists, and dieticians specializing in gastroenterology, surgery, primary care, or internal medicine
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Peek reports the following financial relationships:
Consultant: Pfizer Inc.
Dr. Balzora reports the following financial relationships:
Advisory Board: Janssen Pharmaceuticals, Inc. and Pfizer Inc.
Consultant: AbbVie Inc.
Dr. Bernasko reports the following financial relationships:
Advisory Board: AbbVie Inc.; Boehringer Ingelheim GmbH; Bristol Myers Squibb Company; Eli Lilly and Company; and Janssen Pharmaceuticals, Inc.
Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; and Janssen Pharmaceuticals, Inc.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.